Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications

Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common cause of chronic liver disease worldwide. Characterized by excessive hepatic fat accumulation, this disease encompasses a spectrum from simple steatos...

Full description

Bibliographic Details

Published in:	Livers
Main Authors:	Farah Abdelhameed, Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Subjects:	MASLD NAFLD steatosis liver gut microbiota gut microbiome
Online Access:	https://www.mdpi.com/2673-4389/5/1/11